Plus Therapeutics to Present at the 2nd Annual Targeted Radiopharmaceuticals Summit (GlobeNewswire) - Jul 13, 2023 - "Plus Therapeutics, Inc...today announced that Marc Hedrick, M.D., President and Chief Executive Officer, will give two presentations at the Targeted Radiopharmaceuticals Summit taking place July 25-27, 2023 in Boston, Massachusetts. The presentations will describe data from the ReSPECT-GBM clinical study evaluating the Company's lead radiotherapeutic, rhenium (186Re) obisbemeda, for the treatment of recurrent glioblastoma (rGBM), as well as provide an overview of the Company's scientific approach, current pipeline and a snapshot of where it is headed."
P1/2 data • Pipeline update • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor
|